To determine whether CD93 is required for efficient β1 integrin activation and fibronectin fibrillogenesis during tumor angiogenesis, we analyzed tumor vessels in intracranial GL261 gliomas in WT and CD93–/– mice. The gene discussed is CD93; the disease is central nervous system cancer.